ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $994,000 | +34.1% | 18,750 | 0.0% | 0.31% | +14.2% |
| Q3 2019 | $741,000 | -3.8% | 18,750 | 0.0% | 0.27% | -11.0% |
| Q2 2019 | $770,000 | -11.8% | 18,750 | 0.0% | 0.30% | -15.0% |
| Q1 2019 | $873,000 | +6.9% | 18,750 | 0.0% | 0.35% | -7.1% |
| Q4 2018 | $817,000 | -23.9% | 18,750 | 0.0% | 0.38% | -39.9% |
| Q3 2018 | $1,073,000 | +17.9% | 18,750 | 0.0% | 0.63% | +60.5% |
| Q2 2018 | $910,000 | +24.1% | 18,750 | 0.0% | 0.40% | +10.3% |
| Q1 2018 | $733,000 | – | 18,750 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |